Immunotherapy in Melanoma | Specialty

The OncLive Immunotherapy in Melanoma condition center page is a comprehensive resource for clinical news and expert insights on available and investigational immunotherapies in melanoma and other skin cancers. This page features news articles, interviews in written and video format, and podcasts that focus on updates with checkpoint inhibitors and the ongoing research with this type of treatment.

Frontline Immunotherapy in Advanced Bladder Cancer

December 28th 2017

First-Line Chemotherapy in Advanced Bladder Cancer

December 28th 2017

Advanced Bladder Cancer: Predicting Clinical Response

December 28th 2017

Impact of Immunotherapy in Advanced Bladder Cancer

December 28th 2017

Dr. Atkinson Discusses BRAF-Mutant Metastatic Melanoma

December 22nd 2017

Victoria Atkinson, MD, medical oncologist, Princess Alexandra Hospital, University of Queensland, discusses the treatment landscape for patients with BRAF-mutant metastatic melanoma.

FDA Grants Adjuvant Dabrafenib/Trametinib Priority Review for BRAF+ Melanoma

December 22nd 2017

The FDA has granted a priority review to a supplemental new drug application for the use of dabrafenib combined with trametinib as an adjuvant treatment for patients with BRAF V600E– or V600K–positive stage III melanoma following complete resection.

Gastric/GEJ Cancers: Looking Toward the Future

December 22nd 2017

The Evolving Treatment Landscape in Gastric/GEJ Cancers

December 22nd 2017

Gastric/GEJ Cancers: Non-Immunotherapeutic Advancements

December 22nd 2017

Other Immunotherapy Approaches in Gastric/GEJ Cancers

December 22nd 2017

Emerging Nivolumab Strategies in Gastric/GEJ Cancers

December 22nd 2017

Practical Considerations for Prescribing Immunotherapy

December 22nd 2017

MSI Testing's Impact on Immunotherapy in Gastric Cancers

December 22nd 2017

Immunotherapy in Advanced/Metastatic Gastric/GEJ Cancers

December 22nd 2017

Advanced/Metastatic Gastric Cancer: Beyond Frontline

December 22nd 2017

Treating Unresectable or Metastatic Gastric/GEJ Cancers

December 22nd 2017

Upfront Therapy Approaches in Gastric/GEJ Cancer

December 22nd 2017

Understanding Prognoses of Advanced Gastric/GEJ cancers

December 22nd 2017

The Molecular-Driven Classification of Gastric Cancers

December 22nd 2017

Classification Guidelines for Gastric/GEJ Cancers

December 22nd 2017